Medline Namic Angiographic Control Syringes — recall 81802
Health Canada — Medical Devices · Canada · 2026-03-27 · Type I
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: The Namic RA syringes have been recalled by Medline due to a potential risk of the syringe rotating adaptor unwinding during use. If unwinding occurs, it may result in procedural delays, and in severe cases, death. Customers have been advised to destroy these syringes.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.